Medical Procedure News

RSS

FDA approves Medtronic’s expanded indication for implantable CRT-D devices

Medtronic, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved an expanded indication for its cardiac resynchronization therapy with implantable cardioverter defibrillator (CRT-D) devices.

From Medtronic 11 Apr 2012

Vilex announces commercial launch of FUZE TTC Arthrodesis Compression Nail

Vilex Inc., a leader in innovative orthopaedic medical devices announced the commercial launch of the FUZE TTC Arthrodesis Compression Nail, the most recent addition to the Vilex line.

11 Apr 2012

USPTO issues five patents to VertiFlex Superion ISS

VertiFlex, Inc., a leading innovator of advanced minimally invasive spinal surgery technologies, today announced that the U.S. Patent and Trademark Office has awarded five additional key patents covering the design and implantation method for its unique interspinous spacer technology. The five U.S. patent numbers are 8,012,207, 8,123,807, 8,123,782, 8,128,662, and 8,152,837.

11 Apr 2012

Boston Scientific receives European CE Mark approval for INGENIO family of pacemakers

Boston Scientific Corporation announces CE Mark approval and European market launch of its INGENIO and ADVANTIO pacemakers and INVIVE cardiac resynchronization therapy pacemakers.

11 Apr 2012

NYU Langone announces opening of Center for Musculoskeletal Care

NYU Langone Medical Center ushered in the next generation of orthopaedic, rheumatologic and rehabilitative care with the opening of the Center for Musculoskeletal Care (CMC) at 333 East 38th Street in Manhattan last week.

11 Apr 2012

Intact Vascular’s Tack-it Endovascular Stapler device receives CE Mark approval

Intact Vascular, a medical device company and developer of products for minimally invasive peripheral vascular procedures, today announced its European notified body has granted the company ISO Certification and CE Mark approval for Tack-it Endovascular Stapler device.

11 Apr 2012

Omeros initiates enrollment in second Phase 3 trial of OMS302

Omeros Corporation today announced that patient enrollment has begun in the Company's second Phase 3 clinical trial evaluating OMS302 in intraocular lens replacement (ILR) surgery.

10 Apr 2012

Delcath, NKI-AVL enter initial launch and training agreement for CHEMOSAT system

Delcath Systems, Inc. announced today that the Company has entered into an initial launch and training agreement with the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL) in Amsterdam, The Netherlands.

10 Apr 2012

Viewpoints: Doctors' efforts to cut unnecessary procedures is a good first step

Several news outlets look at the initiative by nine physicians' groups to identify medical procedures which are frequently unneeded and could even be harmful.

10 Apr 2012

FDA selects three renal device projects for new Pathway program

A UCSF-led effort to create an implantable artificial kidney for dialysis patients has been selected as one of the first projects to undergo more timely and collaborative review at the Food and Drug Administration.

10 Apr 2012

UCSD surgeon implants new INX device in a 29-year old patient with GERD

On Monday, April 9, Santiago Horgan, MD, chief of minimally invasive surgery at UC San Diego Health System implanted the new FDA-approved LINX device in a 29-year old patient suffering from gastroesophageal reflux disease (GERD), a chronic digestive disease that can lead to severe inflammation, stricture, Barrett's esophagus and esophageal cancer.

10 Apr 2012

Three NJIT EDC high-tech companies win top awards at 2012 Venture Conference

Three high-tech companies based at NJIT's Enterprise Development Center (EDC) took top awards at the recent 2012 Venture Conference sponsored by the New Jersey Technology Council.

10 Apr 2012

ASPO to hold pediatric otolaryngology meeting from April 18 - April 22

The American Society of Pediatric Otolaryngology (ASPO) will hold its annual meeting, April 18 - April 22, during the 2012 Combined Otolaryngology Spring Meetings (COSM) - a joint meeting of eight otolaryngological societies in San Diego, CA. The meeting will feature dozens of scientific presentations highlighting research in progress in the field of otolaryngology-head and neck surgery.

10 Apr 2012

Top ten facts about organ and tissue donation

Every year, more than 100,000 Americans will need a life-saving organ transplant, yet in 2011 fewer than 22,000 transplants took place in the United States. In New York only 18 percent of New Yorkers who are eligible to donate are registered as organ donors, in stark contrast to the national average of 42 percent.

10 Apr 2012

Changes in corneal thickness occur in patients at early stages of FECD

A national consortium of researchers has published new findings that could change the standard of practice for those treating Fuchs' Endothelial Corneal Dystrophy (FECD), a disease characterized by cornea swelling that can eventually lead to the need for corneal transplantation.

10 Apr 2012

ReCor Medical provides updated data from REDUCE Percutaneous Renal Denervation System study

ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.

10 Apr 2012

Monitoring necessary for early intervention in Fuchs' Endothelial Corneal Dystrophy patients

10 Apr 2012

Survey finds high rating for Heraeus iBOND Self Etch bonding agent

Heraeus Kulzer, LLC, the worldwide leader in dental esthetics, announced today that its iBOND Self Etch bonding agent received the maximum possible "5-plus" rating from THE DENTAL ADVISOR. The iBOND Self Etch bottle kit was evaluated by 26 consultants in 648 uses and received a very impressive 96% clinical rating.

9 Apr 2012

Synapse Medical acquires another MicroThermX Microwave Ablation System

BSD Medical Corporation, a leading provider of medical systems that utilize heat therapy to treat cancer, announced today that the Company has sold an additional MicroThermX Microwave Ablation System to Synapse Medical Ltd.

9 Apr 2012

Chemotherapy based on individual genomes and genomes of tumors

The Breast Cancer Genome Guided Therapy Study (BEAUTY Project) will help physicians tailor chemotherapy to breast cancer patients based on their individual genomes and the genomes of their tumors.

9 Apr 2012